
Sign up to save your podcasts
Or
GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. But what does it feel like for the patients who take them?
On this week’s episode of Well, Now Kavita and Maya talk with journalist and author Johann Hari. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. All the while, he was also taking Ozempic himself.
His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs takes a personal and research-based look at the revolutionary, controversial rise of GLP-1 drugs for weight management.
If you liked this episode, check out: The Full Truth About Ozempic and Doctors Agree: Obesity is a Disease. The Public Needs to Catch Up.
Well, Now is hosted by registered dietitian nutritionist Maya Feller and Dr. Kavita Patel.
Podcast production by Vic Whitley-Berry with editorial oversight by Alicia Montgomery.
Send your comments and recommendations on what to cover to [email protected]
Want to listen to Well, Now uninterrupted? Subscribe to Slate Plus to immediately unlock ad-free listening to Well, Now and all your other favorite Slate podcasts.
Subscribe now on Apple Podcasts by clicking “Try Free” at the top of our show page. Or, visit slate.com/wellplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.6
28482,848 ratings
GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. But what does it feel like for the patients who take them?
On this week’s episode of Well, Now Kavita and Maya talk with journalist and author Johann Hari. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. All the while, he was also taking Ozempic himself.
His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs takes a personal and research-based look at the revolutionary, controversial rise of GLP-1 drugs for weight management.
If you liked this episode, check out: The Full Truth About Ozempic and Doctors Agree: Obesity is a Disease. The Public Needs to Catch Up.
Well, Now is hosted by registered dietitian nutritionist Maya Feller and Dr. Kavita Patel.
Podcast production by Vic Whitley-Berry with editorial oversight by Alicia Montgomery.
Send your comments and recommendations on what to cover to [email protected]
Want to listen to Well, Now uninterrupted? Subscribe to Slate Plus to immediately unlock ad-free listening to Well, Now and all your other favorite Slate podcasts.
Subscribe now on Apple Podcasts by clicking “Try Free” at the top of our show page. Or, visit slate.com/wellplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
9,104 Listeners
3,888 Listeners
8,492 Listeners
38,178 Listeners
2,146 Listeners
1,878 Listeners
992 Listeners
26,146 Listeners
6,289 Listeners
1,016 Listeners
7,712 Listeners
1,013 Listeners
3,461 Listeners
6,623 Listeners
10,639 Listeners
5,656 Listeners
624 Listeners
2,287 Listeners
2,038 Listeners
240 Listeners
23,950 Listeners
2,394 Listeners
1,286 Listeners
15,947 Listeners
1,187 Listeners
414 Listeners
15,285 Listeners
610 Listeners
545 Listeners
59 Listeners
46 Listeners
94 Listeners
6 Listeners